Mayuko Mishima
YOU?
Author Swipe
View article: The novel sustained 3‐hydroxybutyrate donor <scp>poly‐D</scp> ‐3‐hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T‐cells
The novel sustained 3‐hydroxybutyrate donor <span>poly‐D</span> ‐3‐hydroxybutyric acid prevents inflammatory bowel disease through upregulation of regulatory T‐cells Open
Inflammatory bowel disease (IBD) is a chronic persistent intestinal disorder, with ulcerative colitis and Crohn's disease being the most common. However, the physio‐pathological development of IBD is still unknown. Therefore, research on t…